Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells
文献类型：期刊论文
| 作者 | Lin WM1; Karsten U2; Goletz S2; Cheng RC3; Cao Y[*]1 |
| 刊名 | INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
 |
| 出版日期 | 2011 |
| 卷号 | 92期号:2页码:97-105 |
| 关键词 | cancer-initiating cells CD133 CD176 CD44 co-expression Thomsen-Friedenreich antigen |
| 通讯作者 | caoy@mail.kiz.ac.cn |
| 合作状况 | 其它 |
| 英文摘要 | P>The cancer-initiating capacity of most malignant tumours is considered to reside in a small subpopulation of cells. Therapeutical interventions should target these cells rather than the tumour mass. Numerous studies have shown that the carbohydrate antigen structure CD176 (Thomsen-Friedenreich antigen, core-1) is present in many types of cancer and absent in normal adult human tissues. In this study, we assessed whether CD176 is co-expressed with CD44 or CD133 [markers of cancer-initiating cells (CIC)] in human lung, breast and liver carcinoma. A variety of human cancer cell lines and surgical specimens of these malignancies were examined. It was found that in most cases the majority of tumour cells stained strongly for CD44 by immunohistochemistry and flow cytometry, whereas CD133 expression was found on a smaller, but varying proportion of cells. Co-expression of CD176 with CD44 was found at a surprisingly high percentage of cancer cells in vitro and in vivo. Co-expression of CD176 with CD133 was also detected, although at a lower rate. Tamoxifen treatment of MDA-435 breast cancer cells enhanced the CD44+/CD176+ phenotype. Evidence is provided through a new sandwich solid-phase enzyme-linked immunosorbent assay (ELISA) suggesting that CD44 is a carrier molecule for CD176 not only in colorectal cancer as previously reported, but also in lung, breast and liver cancer. The expression of CD176 in CIC suggests that it may represent an effective target for tumour therapies. |
| 收录类别 | SCI |
| 资助信息 | This research was supported by a grant from Yunnan Province Science and Technology Department (2008CCO15). |
| 语种 | 英语 |
| 公开日期 | 2011-04-25 |
| 源URL | [http://159.226.149.42:8088/handle/353002/6605]  |
| 专题 | 昆明动物研究所_分子病理学 昆明动物研究所_动物模型与人类重大疾病机理重点实验室 |
| 作者单位 | 1.Key Laboratory of Animal Models and Human Disease Mechanisms of CAS and Yunnan Province, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China 2.Glycotope GmbH, Berlin-Buch, Germany 3.Department of General Surgery, First Affiliated Hospital of Kunming Medical College, Kunming, China |
| 推荐引用方式 GB/T 7714 | Lin WM,Karsten U,Goletz S,et al. Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells[J]. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY,2011,92(2):97-105. |
| APA | Lin WM,Karsten U,Goletz S,Cheng RC,&Cao Y[*].(2011).Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells.INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY,92(2),97-105. |
| MLA | Lin WM,et al."Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells".INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 92.2(2011):97-105. |
入库方式： OAI收割
来源：昆明动物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。